Recently, Director Sun Jie, head of the Shanghai Urology Department for Prostate Hyperplasia, completed three cases of “Rezūm” prostate hyperplasia thermal steam ablation surgery in the operating room in Shanghai. Although the three patients were of different ages, they all suffered from urination problems caused by prostate hyperplasia.

Mr. Shi (pseudonym), 70 years old, suffers from benign prostatic hyperplasia, and has long-term dysuria and frequent urination. He had a cerebral infarction one year ago and has been taking anticoagulants. While considering the surgical method, he is also concerned about the risks of surgical anesthesia. Through in-depth communication with Director Sun Jie in the outpatient clinic, Director Sun Jie recommended the “Rezūm” prostatic hyperplasia thermal steam ablation surgery to Mr. Shi, which can reduce the anesthesia risk and solve the urination problems caused by prostatic hyperplasia.

63-year-old patient Lao Liu (pseudonym) and 60-year-old foreign patient James (pseudonym) from the United States have been taking drugs to treat prostate hyperplasia for many years and have never made up their minds to undergo traditional surgery. The possible risk of urinary incontinence and the impact on sexual function after surgery are the main factors that have influenced them to undergo surgery.

After hearing that the “Rezūm” prostate hyperplasia thermal steam ablation surgery is an ultra-minimally invasive surgery with guaranteed surgical safety, a single operation time of only about 5-10 minutes, minimal trauma and less bleeding, effective reduction of postoperative infection, definite effect, and can protect male sexual function to the greatest extent, and that the surgery can be completed under local anesthesia, which can greatly reduce the risk of anesthesia, they also chose the “Rezūm” prostate hyperplasia thermal steam ablation surgery.

(Director Sun Jie during surgery)

The application of “Rezūm” thermal steam ablation surgery for prostate hyperplasia in Shanghai has given new hope to many patients with prostate hyperplasia. This surgery is currently recognized as one of the advanced minimally invasive surgical methods for prostate hyperplasia, and a total of 150,000 cases have been completed worldwide.

As an alternative to prostate medication or transurethral resection surgery, “Rezūm” prostate hyperplasia thermal vapor ablation surgery mainly injects 103°C sterile water vapor into the hyperplastic tissue in the target area through a guide needle. The water vapor is quickly distributed in the hyperplastic tissue, causing the temperature of the hyperplastic tissue to reach 70°C and induce the hyperplastic tissue to lose activity, necrotize and shrink, and be absorbed by the human body.

Illustration of Ruimeng thermal steam ablation process:

(Image source: Boston Scientific)